CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 26 enrolled
Drug / intervention
Escitalopramdrug
Likely dose
Escitalopram 20mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01271244
NCT01271244Phase 4Completed
CompareCT.gov

Effects of Escitalopram on Autonomic Reactivity in Post Traumatic Stress Disorder Among Veterans of Operation Enduring Freedom and Iraqi Freedom (OEF/OIF)

VA Nebraska Western Iowa Health Care System·interventional·Posted Jan 6, 2011·Updated May 7, 2019

In Brief

A Phase 4 clinical trial evaluating Escitalopram for PTSD. Completed, enrolled 26 participants across 1 site.

Detailed Summary

The study looked at relationship between escitalopram and heart rate variability and QT variability in veterans with PTSD.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPTSD
CountriesUnited States
CollaboratorsForest Laboratories

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 6, 2011
Enrollment StartJun 1, 2008
Primary CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 15.5 years ago

Interventions

Escitalopramdrug

10-20mg daily for 12 weeks